Right Ventricular Failure After Cardiac Surgery: Management Strategies

Seminars in Thoracic and Cardiovascular Surgery

Volumn 24, Issue 3, 2012, Pages 188-194

  Itagaki, Shinobu ^a   Hosseinian, Leila ^a   Varghese, Robin ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; ENDOTHELIN RECEPTOR ANTAGONIST; ILOPROST; ISOPRENALINE; LEVOSIMENDAN; MILRINONE; NITRIC OXIDE; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN; PROSTAGLANDIN E1; SILDENAFIL;

ARTICLE; COUNTERPULSATION; DRUG ACTIVITY; DRUG HALF LIFE; DRUG POTENCY; DRUG POTENTIATION; DRUG SELECTIVITY; DRUG WITHDRAWAL; HEART AFTERLOAD; HEART PRELOAD; HEART RIGHT VENTRICLE ENDDIASTOLIC VOLUME; HEART RIGHT VENTRICLE FAILURE; HEART SURGERY; HEART VENTRICLE CONTRACTILITY; HUMAN; HYPERVOLEMIA; HYPOTENSION; HYPOVOLEMIA; INTENSIVE CARE UNIT; INTRAAORTIC BALLOON PUMP; INTRAOPERATIVE PERIOD; LEFT VENTRICULAR ASSIST DEVICE; LIVER TOXICITY; LUNG VASCULAR RESISTANCE; METHEMOGLOBINEMIA; POSITIVE END EXPIRATORY PRESSURE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; TACHYCARDIA;

CARDIAC SURGICAL PROCEDURES; CARDIOTONIC AGENTS; FLUID THERAPY; HEART FAILURE; HUMANS; REOPERATION; RESPIRATION, ARTIFICIAL; TREATMENT OUTCOME; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR FUNCTION, RIGHT;

EID: 84870440935     PISSN: 10430679     EISSN: 15329488     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2012.08.001     Document Type: Article

References (30)

1. Haddad F., Hunt S.A., Rosenthal D.N., et al. Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation 2008, 117:1436-1448.
2. Lahm T., McCaslin C.A., Wozniak T.C., et al. Medical and surgical treatment of acute right ventricular failure. J Am Coll Cardiol 2010, 56:1435-1446.
3. Goldstein J.A., Harada A., Yagi Y., et al. Hemodynamic importance of systolic ventricular interaction, augmented right atrial contractility and atrioventricular synchrony in acute right ventricular dysfunction. J Am Coll Cardiol 1990, 16:181-189.
4. Kaul T.K., Fields B.L. Postoperative acute refractory right ventricular failure: Incidence, pathogenesis, management and prognosis. Cardiovasc Surg 2000, 8:1-9.
5. Goldstein J.A., Barzilai B., Rosamond T.L., et al. Determinants of hemodynamic compromise with severe right ventricular infarction. Circulation 1990, 82:359-368.
6. Voelkel N.F., Quaife R.A., Leinwand L.A., et al. Right ventricular function and failure: Report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation 2006, 114:1883-1891.
7. Jardin F., Vieillard-Baron A. Right ventricular function and positive pressure ventilation in clinical practice: From hemodynamic subsets to respirator settings. Intensive Care Med 2003, 29:1426-1434.
8. Kormos R.L., Teuteberg J.J., Pagani F.D., et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: Incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg 2010, 139:1316-1324.
9. Fukamachi K., Shiose A., Massiello A.L., et al. Implantable continuous-flow right ventricular assist device: Lessons learned in the development of a Cleveland Clinic device. Ann Thorac Surg 2012, 93:1746-1752.
10. Kavarana M.N., Pessin-Minsley M.S., Urtecho J., et al. Right ventricular dysfunction and organ failure in left ventricular assist device recipients: A continuing problem. Ann Thorac Surg 2002, 73:745-750.
11. Vargas Abello L.M., Klein A.L., Marwick T.H., et al. Understanding right ventricular dysfunction and functional tricuspid regurgitation accompanying mitral valve disease. J Thorac Cardiovasc Surg 2012 May 22, (Epub ahead of print).
12. Anyanwu A.C., Chikwe J., Adams D.H. Tricuspid valve repair for treatment and prevention of secondary tricuspid regurgitation in patients undergoing mitral valve surgery. Curr Cardiol Rep 2008, 10:110-117.
13. Rudski L.G., Lai W.W., Afilalo J., et al. Guidelines for the echocardiographic assessment of the right heart in adults: A report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010, 23:685-713. quiz 786-788.
14. Vizza C.D., Rocca G.D., Roma A.D., et al. Acute hemodynamic effects of inhaled nitric oxide, dobutamine and a combination of the two in patients with mild to moderate secondary pulmonary hypertension. Crit Care 2001, 5:355-361.
15. Mentzer R.M., Alegre C.A., Nolan S.P. The effects of dopamine and isoproterenol on the pulmonary circulation. J Thorac Cardiovasc Surg 1976, 71:807-814.
16. Chen E.P., Bittner H.B., Davis R.D., et al. Milrinone improves pulmonary hemodynamics and right ventricular function in chronic pulmonary hypertension. Ann Thorac Surg 1997, 63:814-821.
17. Barraud D., Faivre V., Damy T., et al. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: Comparison with dobutamine and milrinone. Crit Care Med 2007, 35:1376-1382.
18. Ukkonen H., Saraste M., Akkila J., et al. Myocardial efficiency during levosimendan infusion in congestive heart failure. Clin Pharmacol Ther 2000, 68:522-531.
19. Kopustinskiene D.M., Pollesello P., Saris N.E. Levosimendan is a mitochondrial K(ATP) channel opener. Eur J Pharmacol 2001, 428:311-314.
20. Channick R.N., Hoch R.C., Newhart J.W., et al. Improvement in pulmonary hypertension and hypoxemia during nitric oxide inhalation in a patient with end-stage pulmonary fibrosis. Am J Respir Crit Care Med 1994, 149:811-814.
21. Stobierska-Dzierzek B., Awad H., Michler R.E. The evolving management of acute right-sided heart failure in cardiac transplant recipients. J Am Coll Cardiol 2001, 38:923-931.
22. Christenson J., Lavoie A., O'Connor M., et al. The incidence and pathogenesis of cardiopulmonary deterioration after abrupt withdrawal of inhaled nitric oxide. Am J Respir Crit Care Med 2000, 161:1443-1449.
23. Barst R.J., Rubin L.J., Long W.A., et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. N Engl J Med 1996, 334:296-302.
24. Price L.C., Wort S.J., Finney S.J., et al. Pulmonary vascular and right ventricular dysfunction in adult critical care: Current and emerging options for management: A systematic literature review. Crit Care 2010, 14:R169.
25. Lepore J.J., Maroo A., Bigatello L.M., et al. Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: Combined administration with inhaled nitric oxide. Chest 2005, 127:1647-1653.
26. Badesch D.B., Abman S.H., Simonneau G., et al. Medical therapy for pulmonary arterial hypertension: Updated ACCP evidence-based clinical practice guidelines. Chest 2007, 131:1917-1928.
27. Fischer L.G., Van Aken H., Bürkle H. Management of pulmonary hypertension: Physiological and pharmacological considerations for anesthesiologists. Anesth Analg 2003, 96:1603-1616.
28. Theres H., Binkau J., Laule M., et al. Phase-related changes in right ventricular cardiac output under volume-controlled mechanical ventilation with positive end-expiratory pressure. Crit Care Med 1999, 27:953-958.
29. Krishan K., Nair A., Pinney S., et al. Liberal use of tricuspid-valve annuloplasty during left-ventricular assist device implantation. Eur J Cardiothorac Surg 2012, 41:213-217.
30. Loebe M., Bruckner B., Reardon M.J., et al. Initial clinical experience of total cardiac replacement with dual HeartMate-II axial flow pumps for severe biventricular heart failure. Methodist Debakey Cardiovasc J 2011, 7:40-44.